The Valley Desk

Clinical trial reportThe oncologistPublished

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The oncologist
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Anilides; Pyridines; Recombinant Fusion Proteins; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
40549043
PubMed Central ID
PMC12205982
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal